April 01, 2022 at 02:03AM 2022_03 Test Article EDITED FT 02

2022_03 Test Article some long description some long description.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/HBsmhRG

March 31, 2022 at 10:31PM Webinars and Outreach

CBER sponsored webinars for public and industry.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/v6a3CdP

March 31, 2022 at 02:42PM Vaccine and Related Biological Product Guidances

This page contains a listing of vaccine and related biological product guidances

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/OcfsE7G

March 31, 2022 at 02:42PM Emergency Use Authorization for Vaccines to Prevent COVID-19

This is the Guidance for Industry for the Emergency Use Authorization for Vaccines to Prevent COVID-19. , COVID-19, Coronavirus Disease 2019, Vaccines , CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8yDHpVF

Wednesday, March 30, 2022

March 30, 2022 at 08:42PM RegenMedEd Webinar: The Critical Role of Patients in Advancing Gene Therapy Treatments for Rare Diseases - 03/09/2022

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a public webinar on Wednesday, March 9, 2022, from 11:00 a.m. - 12:00 p.m. ET.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8G4E1XQ

March 30, 2022 at 04:46PM FDA’s Technology and Data Modernization in Action in 2022

As we mark the one-year anniversary of the agency’s Data Modernization Action Plan, and nearly three years since launching the agency’s Technology Modernization Action Plan, we are pleased to provide an update on our progress with the report: “Modernization in Action.”

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/qhkoGAr

Tuesday, March 29, 2022

March 29, 2022 at 09:48PM CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19

CDER Scientific Reviews Supporting EUA for Therapeutic Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/lLpzwvu

March 29, 2022 at 09:17PM Do I qualify for a COVID-19 vaccine booster and which one?

Do I qualify for a COVID-19 vaccine booster and which one?

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/txn5qE6

March 29, 2022 at 06:01PM Comirnaty and Pfizer-BioNTech COVID-19 Vaccine

Information about the Comirnaty and Pfizer-BioNTech COVID-19 Vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/MOxdN8Z

March 29, 2022 at 04:30PM Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals

The FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bsIjqRo

March 29, 2022 at 03:35PM Vaccines and Related Biological Products Advisory Committee April 6, 2022 Meeting Announcement - 04/06/2022

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee April 6, 2022 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/u1jZOn3

Monday, March 28, 2022

March 28, 2022 at 11:04PM Devices Guidances

This page lists Medical Device Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Jlpfdb2

March 28, 2022 at 10:11PM Administrative Guidances

This page lists Administrative Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/aYle875

Friday, March 25, 2022

March 25, 2022 at 08:19PM Vaccines and Related Biological Products Advisory Committee March 3, 2022 Meeting Announcement - 03/03/2022

This is the CBER Vaccines and Related Biological Products Advisory Committee March 3, 2022 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/pvNynIi

March 24, 2022 at 01:43PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XcqMGxy

March 18, 2022 at 02:54PM CROFAB

CroFab is indicated for the management of adult and pediatric patients with North American crotalid envenomation.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vaksJTL

March 21, 2022 at 02:02PM Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters

On Wed., April 6, FDA will hold a virtual meeting of its Vaccines and Related Biological Products Advisory Committee to discuss considerations for future COVID-19 vaccine booster doses and the strain selection process to address current and emerging variants during the Fall season 2022.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/iM5rEX6

March 18, 2022 at 09:34PM 2022 Meeting Materials, Vaccines and Related Biological Products Advisory Committee

This is the main page for the CBER 2022 Meeting Materials, Vaccines and Related Biological Products Advisory Committee (VRBPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/BgJlj92

March 18, 2022 at 01:49PM CARVYKTI

For the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/r35YZS6

Thursday, March 17, 2022

March 17, 2022 at 04:17PM APTIMA HIV-1 RNA Qualitative Assay

Product approval information is indicated for use as an aid in diagnosis of HIV-1 infection, including acute or primary infection.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/MaEop6N

March 17, 2022 at 04:14PM Zoster Vaccine Recombinant, Adjuvanted

Zoster Vaccine Recombinant, Adjuvanted

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/LOroRzw

March 17, 2022 at 03:52PM Typhoid Vi Polysaccharide Vaccine

List of Typhoid Vi Polysaccharide Vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7DKuM2X

March 17, 2022 at 03:50PM Typhoid Vaccine Live Oral Ty21a

Typhoid Vaccine Live Oral Ty21a

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/1VpKfnJ

March 17, 2022 at 03:40PM Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)

List of Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein) products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/JWMRX9K

Wednesday, March 16, 2022

March 16, 2022 at 03:34PM Section 8500: Compliance

This is the SOPP Section 8500: Compliance main page.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jkzahxq

March 16, 2022 at 02:27PM Spikevax and Moderna COVID-19 Vaccine

Information about the Moderna COVID-19 Vaccine and Spikevax

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/drjCT28

March 14, 2022 at 06:48PM Developing Predictive Indicators of Genome Stability and Cell Maturation as Measures of Cell Therapy Product Safety and Efficacy

A description of Deborah Hursh's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hrt4viS

March 14, 2022 at 02:47PM Janssen COVID-19 Vaccine

Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kteTdP5

Friday, March 11, 2022

March 11, 2022 at 10:32PM FDA Roundup: March 11, 2022

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/42TBmYS

March 11, 2022 at 09:34PM Q&A for Spikevax (COVID-19 Vaccine mRNA)

Q&A document with information about FDA's recent approval of Moderna's Spikevax (COVID-19 Vaccine, mRNA).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/qAX3pkn

March 11, 2022 at 04:04PM Vivaglobin

Product approval information is indicated for treatment of patients with primary immune deficiency (PID.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/etfd1Uy

Thursday, March 10, 2022

March 10, 2022 at 04:54PM FDA Taking New Steps to Better Inform Physicians about Biosimilars Through Education about these Potentially Cost-Saving Options

FDA Taking New Steps to Better Inform Physicians about Biosimilars Through Education about these Potentially Cost-Saving Options

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/i1bBqW0

March 10, 2022 at 04:48PM You Spoke, FDA Listened: New Patient Engagement Collaborative, Call for Nominations

The FDA is committed to collaborating with patients, caregivers, and advocates, as well as incorporating the various perspectives from these groups into the FDA’s regulatory decision-making processes.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/g8JXbLE

March 10, 2022 at 04:44PM FDA Blood Supply and Demand Simulation Model Could Help Nation Prepare for Emergencies

FDA Blood Supply and Demand Simulation Model Could Help Nation Prepare for Emergencies

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zJXrY59

March 10, 2022 at 04:21PM Predicting Stem Cell Activity to Ensure Safe and Effective Therapies

Predicting Stem Cell Activity to Ensure Safe and Effective Therapies

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bqDlsnC

March 10, 2022 at 04:11PM FDA Budget Matters: A Cross-Cutting Data Enterprise for Real World Evidence

FDA Budget Matters: A Cross-Cutting Data Enterprise for Real World Evidence

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/HfUjN39

March 10, 2022 at 04:10PM FDA Budget Matters: Investing in Advanced Domestic Manufacturing

FDA Budget Matters: Investing in Advanced Domestic Manufacturing

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6xWCNuJ

March 10, 2022 at 03:53PM Protecting and Promoting Public Health: Advancing the FDA’s Medical Countermeasures Mission

Protecting and Promoting Public Health: Advancing the FDA’s Medical Countermeasures Mission

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/xHGAh9J

March 10, 2022 at 03:10PM FDA Protecting the Nation Through Medical Countermeasures

The FDA works closely with the U.S. Department of Defense to promote the development and availability of medical countermeasures to support the American military personnel’s unique needs. Learn about medical countermeasures, what they are and how they impact public health.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/qxNjR8b

Wednesday, March 9, 2022

March 09, 2022 at 05:47PM FDA Public Meeting: Identification of Concepts and Terminology for Multi-Component Biomarkers - 03/23/2022

The FDA Center for Drug Evaluation and Research and the FDA Biomarker Working Group will convene a virtual workshop on March 23-24, 1-3 PM (EST) entitled “Identification of Concepts and Terminology for Multi-Component Biomarkers”. The workshop is intended to develop multi-component biomarker concepts and terminology to identify areas of conceptual

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ArHecBa

March 09, 2022 at 05:27PM Section 8000: General Information

This is the main page for CBER's SOPP Section 8000: General Information.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6Cc1OJz

March 09, 2022 at 03:00PM Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs

Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs Guidance for Industry

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/F5dxUrH

March 09, 2022 at 02:20PM Cellular, Tissue, and Gene Therapies Advisory Committee March 10, 2022 Meeting Announcement - 03/10/2022

This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee March 10, 2022 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eFECxkR

Tuesday, March 8, 2022

March 08, 2022 at 05:31PM Innovative Regenerative Medicine Therapies – Patient Safety Comes First

Cellular-derived therapies, including stem cell-based products, offer the potential to treat or even cure diseases or conditions for which few effective treatment options exist.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WUpX8Cz

March 08, 2022 at 05:26PM FDA’s Budget: Data Modernization and Enhanced Technologies

FDA’s FY 2022 Budget includes funding for an agency-wide data modernization and enhanced technologies initiative that supports both food safety and medical product safety programs.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/SoDhqs5

March 08, 2022 at 05:19PM FDA to Discuss COVID-19’s Impact on Medical Product Operations at SBIA REdI Annual Conference

FDA will co-host the Small Business Industry and Assistance (SBIA) Regulatory Education for Industry (REdI) Annual Conference, which will provide an overview of our regulatory operations during COVID-19.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/iZICXHe

March 08, 2022 at 05:16PM Global Regulators Envision Paradigm Shift Toward Inclusion of Pregnant and Breastfeeding Women in Clinical Research for Medicines and Vaccines

A major paradigm shift is necessary from the systemic exclusion to the inclusion of pregnant and breastfeeding women in clinical studies.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/X968ux3

March 08, 2022 at 05:14PM FDA Seeks Patient Insight: Call for Applications for the Patient Engagement Collaborative

The FDA is announcing the call for applications for the next cohort of the Patient Engagement Collaborative.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/y8HpOcm

March 08, 2022 at 05:07PM FDA’s National Center for Toxicological Research Celebrates Half a Century of Cutting-Edge Research

NCTR is celebrating 50 years of scientific achievements including the groundbreaking research we have done—and continue to do—in support of the FDA’s mission.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/qNgA26Z

March 08, 2022 at 04:29PM Fulfilling Essential Public Health Needs in 2022

The FDA’s public health mission, although most apparent during emergencies, is actually in operation every day of every year, protecting the American public from many threats.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/NUW60cB

March 08, 2022 at 04:27PM Many Important Drugs Approved in 2021 as COVID-19 Pandemic Continues

CDER approved a wide variety of safe and effective new drug therapies in 2021 despite challenges brought on by the ongoing COVID-19 pandemic.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Y8iKFle

Monday, March 7, 2022

March 07, 2022 at 07:39PM Virus Entry and Its Inhibition by Antibodies: Studies to Aid the Development and Evaluation of Vaccines that Protect against Viral Infectious Diseases

A description of Carol Weiss's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2a76OU9

March 07, 2022 at 05:42PM Section 8400: Marketing Applications

This is the SOPP Section 8400: Marketing Applications main page.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/9rh6bkJ

March 07, 2022 at 03:56PM RAPLIXA

Product approval information is indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Umw7pR6

March 04, 2022 at 06:13PM Profilnine SD - Factor IX Complex

Product approval information is indicated for the prevention and control of bleeding in patients with Factor IX deficiency due to hemophilia B.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ciKl2r8